Dasiglucagon - Zealand Pharma

Drug Profile

Dasiglucagon - Zealand Pharma

Alternative Names: HypoPal® rescue pen; ZP 4207; ZP-GA-1

Latest Information Update: 15 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Zealand Pharma
  • Developer Beta Bionics; Boston University; Zealand Pharma
  • Class Antihypoglycaemics; Peptides
  • Mechanism of Action Glucagon receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hyperinsulinaemia
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Hypoglycaemia
  • Phase II Type 1 diabetes mellitus
  • Phase I Hyperinsulinaemia

Most Recent Events

  • 08 Jun 2018 Adverse events data from a phase III trial in Hypoglycaemia released by Zealand Pharma
  • 28 May 2018 Zealand Pharma completes the phase III trial for Hypogycaemia in Austria, Canada, Germany and USA (SC) (NCT03378635) (EudraCT2017-002449-31)
  • 11 Apr 2018 Zealand Pharma establishes collaboration with Roche Diabetes Care to use its Accu-Chek® Combo pump system in the planned phase III trials
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top